Portfolio concentration
As of February 28, 2026 · N-PORT
Holdings
40
Top-10 weight
52.44%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
25
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
323.4
Holdings
As of February 28, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | COGENT BIOSCIENCES INC | — | 222,753 | $8.65M | 9.05% |
| 2 | LIVANOVA PLC | — | 99,696 | $7.04M | 7.36% |
| 3 | TRANSMEDICS GROUP INC | — | 34,639 | $5.03M | 5.26% |
| 4 | MIRUM PHARMACEUTICALS INC | — | 50,148 | $4.63M | 4.84% |
| 5 | TRAVERE THERAPEUTICS INC | — | 148,543 | $4.43M | 4.63% |
| 6 | SPYRE THERAPEUTICS INC | — | 97,976 | $4.21M | 4.41% |
| 7 | UNITED THERAPEUTICS CORP DEL | — | 8,260 | $4.16M | 4.35% |
| 8 | GUARDANT HEALTH INC | — | 44,027 | $4.13M | 4.32% |
| 9 | WAVE LIFE SCIENCES LTD | — | 288,933 | $4.02M | 4.21% |
| 10 | SAVARA INC | — | 641,260 | $3.86M | 4.04% |
| 11 | KALVISTA PHARMACEUTICALS INC | — | 223,591 | $3.64M | 3.81% |
| 12 | NEKTAR THERAPEUTICS | — | 50,114 | $3.46M | 3.61% |
| 13 | ICU MEDICAL INC | — | 19,228 | $2.90M | 3.03% |
| 14 | TREVI THERAPEUTICS INC | — | 228,121 | $2.72M | 2.84% |
| 15 | BRIDGEBIO PHARMA INC | — | 36,868 | $2.45M | 2.56% |
| 16 | ACADIA PHARMACEUTICALS INC | — | 95,052 | $2.33M | 2.44% |
| 17 | INTEGER HOLDINGS CORP | — | 24,094 | $2.09M | 2.18% |
| 18 | AXSOME THERAPEUTICS INC | — | 12,536 | $2.05M | 2.15% |
| 19 | COLLEGIUM PHARMACEUTICAL INC | — | 47,276 | $1.97M | 2.06% |
| 20 | MADRIGAL PHARMACEUTICALS INC | — | 3,894 | $1.68M | 1.76% |
| 21 | CERIBELL INC | — | 87,031 | $1.62M | 1.70% |
| 22 | GLOBUS MEDICAL INC | — | 16,017 | $1.53M | 1.60% |
| 23 | CORCEPT THERAPEUTICS INC | — | 40,595 | $1.45M | 1.52% |
| 24 | WAYSTAR HOLDING CORP | — | 54,333 | $1.39M | 1.46% |
| 25 | LUMEXA IMAGING H | — | 93,554 | $1.32M | 1.38% |
| 26 | CYTOKINETICS INC | — | 21,236 | $1.32M | 1.38% |
| 27 | BILLIONTOONE INC | — | 16,657 | $1.27M | 1.33% |
| 28 | XERIS BIOPHARMA HOLDINGS INC | — | 204,432 | $1.25M | 1.31% |
| 29 | ALPHATEC HOLDINGS INC | — | 76,228 | $1.04M | 1.09% |
| 30 | RADNET INC | — | 14,680 | $1.02M | 1.07% |
| 31 | HINGE HEALTH INC | — | 23,847 | $1.02M | 1.07% |
| 32 | SOLENO THERAPEUTICS INC | — | 26,025 | $1.02M | 1.06% |
| 33 | CORVUS PHARMACEUTICALS INC | — | 52,479 | $958.27K | 1.00% |
| 34 | INSMED INC | — | 5,962 | $890.31K | 0.93% |
| 35 | AVEANNA HEALTHCARE HOLDINGS INC | — | 104,190 | $766.84K | 0.80% |
| 36 | KORRO BIO INC | — | 61,915 | $751.03K | 0.79% |
| 37 | F/m US Treasury 6 Month Bill ETF | XBIL | 12,655 | $633.26K | 0.66% |
| 38 | F/m Ultrashort Treasury Inflation-Protected Security TIPS ETF | RBIL | 10,720 | $533.32K | 0.56% |
| 39 | NEOGENOMICS INC | — | 42,429 | $417.08K | 0.44% |
| 40 | U.S. Bank Money Market Deposit Account | USBFS04 | 271 | $271 | 0.00% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.